Effect of nimbadi guggulu and shadbindu ghrit nasya in ardhavbhedak

A comparative clinical study to evaluate the efficacy of nimbadi guggulu and shadbindu ghrit nasya in the management of ardhavbhedak w.s.r to migraine - Nil

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/10/075987

Enrollment

Registered

2024-10-28

Start date

Unknown

Completion date

Unknown

Last updated

2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R51- Headache

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients willing for trial. 2.chronicity not exceeding more than 10 years.

Exclusion criteria

Exclusion criteria: 1.Age beloe 18 or more than 70 years. 2.who are taking other preventive treatment. 3.suffering from other chronic diseases. 4.suffering from secondary headache of meningitis , brain tumor , encephalitis or having referred pain on one half of the head due to disorders of eye, ear, nose, throat etc. 5.Evidence of significantly active psychiatric disease including manic depressive illness , schizophrenia, genralized anxiety disorder , OCD , and personality disorder. 6.Women who are pregnant or nursing. 7.Patients with excessive alcoholic ,opiate, barbiturate use. 8.Pt. with h/o drug dependence or drug abuse.

Design outcomes

Primary

Measure	Time frame
Chnages in subjective and objective criteria of Ardhavbhedak (migraine)Timepoint: 60 days	—

Secondary

Measure	Time frame
Efficacy of treatmentTimepoint: 15th day, 30th day, 45th day, 60th day	—

Countries

India

Contacts

Public ContactDr Ayushi chhipa

madan mohan malviya govt. ayurved college udaipur rajasthan

rspgkcj2015@gmail.com9414419259

Outcome results